drugset / Trial / NCT01860664
Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of hydrocortisone ophthalmic ointment compared to placebo in the treatment of Allergic Conjunctivitis.
Timeline
- Start
- 2013-05
- Primary completion
- 2016-05
- Completion
- 2017-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 0.0025 g | Topical |